SI0917466T1 - Oralno kontracepcijsko sredstvo - Google Patents
Oralno kontracepcijsko sredstvoInfo
- Publication number
- SI0917466T1 SI0917466T1 SI9730679T SI9730679T SI0917466T1 SI 0917466 T1 SI0917466 T1 SI 0917466T1 SI 9730679 T SI9730679 T SI 9730679T SI 9730679 T SI9730679 T SI 9730679T SI 0917466 T1 SI0917466 T1 SI 0917466T1
- Authority
- SI
- Slovenia
- Prior art keywords
- combination
- daily dosage
- phase
- administered
- days
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68678696A | 1996-07-26 | 1996-07-26 | |
| PCT/US1997/012786 WO1998004268A1 (en) | 1996-07-26 | 1997-07-23 | Oral contraceptive |
| EP97935047A EP0917466B1 (en) | 1996-07-26 | 1997-07-23 | Oral contraceptive |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI0917466T1 true SI0917466T1 (sl) | 2005-02-28 |
Family
ID=24757747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI9730679T SI0917466T1 (sl) | 1996-07-26 | 1997-07-23 | Oralno kontracepcijsko sredstvo |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0917466B1 (sl) |
| JP (1) | JP2000515888A (sl) |
| KR (1) | KR100501021B1 (sl) |
| CN (1) | CN1119999C (sl) |
| AT (1) | ATE278406T1 (sl) |
| AU (1) | AU713016B2 (sl) |
| BR (1) | BR9710565A (sl) |
| CA (1) | CA2261687A1 (sl) |
| DE (1) | DE69731092T2 (sl) |
| DK (1) | DK0917466T3 (sl) |
| ES (1) | ES2229378T3 (sl) |
| HU (1) | HUP9904345A3 (sl) |
| IL (1) | IL127923A (sl) |
| NZ (1) | NZ333862A (sl) |
| PT (1) | PT917466E (sl) |
| SI (1) | SI0917466T1 (sl) |
| WO (1) | WO1998004268A1 (sl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4344462C2 (de) | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| FR2754179B1 (fr) | 1996-10-08 | 1998-12-24 | Theramex | Nouvelle composition hormononale et son utilisation |
| EP1214076B1 (en) * | 1999-08-31 | 2003-11-19 | Schering Aktiengesellschaft | Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive |
| FR2801218B1 (fr) * | 1999-11-23 | 2001-12-28 | Hoechst Marion Roussel Inc | Compositions pharmaceutiques comprenant de la trimegestone, leurs procedes de preparation ainsi que le conditionnement primaire les renfermant |
| US7297688B2 (en) * | 2000-06-08 | 2007-11-20 | Wyeth | Starter kit for low dose oral contraceptives |
| US7569560B2 (en) | 2004-03-19 | 2009-08-04 | Warner Chilcott Company Llc | Extended cycle multiphasic oral contraceptive method |
| DE102004019743B4 (de) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Mehrphasenpräparat zur Kontrazeption auf der Basis eines natürlichen Estrogens |
| US8022053B2 (en) * | 2004-11-02 | 2011-09-20 | Bayer Schering Pharma Aktiengesellschaft | Oral solid dosage forms containing a low dose of estradiol |
| US7704984B2 (en) * | 2005-04-22 | 2010-04-27 | Warner Chilcott Company, Llc | Extended estrogen dosing contraceptive regimen |
| DE102005034498A1 (de) * | 2005-07-20 | 2007-01-25 | Grünenthal GmbH | Orale Kontrazeption mit Trimegeston |
| US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
| US8063030B2 (en) | 2006-03-02 | 2011-11-22 | Warner Chilcott Company, Llc | Extended cycle multiphasic oral contraceptive method |
| EP1930010A1 (de) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Verwendung von Estradiolvalerat oder 17ß-Estradiol in Kombination mit Dienogest zur oralen Therapie für den Erhalt und/oder die Steigerung der weiblichen Libido |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2365103C3 (de) * | 1973-12-21 | 1980-08-28 | Schering Ag, 1000 Berlin Und 4619 Bergkamen | V erwendung von Hormonen zur Kontrazeption |
| US4628051A (en) * | 1983-09-26 | 1986-12-09 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| US4616006A (en) * | 1983-09-26 | 1986-10-07 | Ortho Pharmaceutical Corporation | Triphasic oral contraceptive |
| AU630334B2 (en) * | 1987-09-24 | 1992-10-29 | Jencap Research Ltd. | Hormone preparations for hormone replacement therapy and contraceptive method |
| IE71203B1 (en) * | 1990-12-13 | 1997-02-12 | Akzo Nv | Low estrogen oral contraceptives |
| IE62665B1 (en) * | 1990-12-17 | 1995-02-22 | Akzo Nv | Contraceptive regimen |
| DE4313926A1 (de) * | 1993-04-28 | 1994-11-03 | Jenapharm Gmbh | Pharmazeutisches Mehrphasenpräparat zur hormonalen Kontrazeption |
| NL9301562A (nl) * | 1993-09-09 | 1995-04-03 | Saturnus Ag | Preparaat voor substitutietherapie. |
| DE4344462C2 (de) * | 1993-12-22 | 1996-02-01 | Schering Ag | Zusammensetzung für die Empfängnisverhütung |
| DE4411585A1 (de) * | 1994-03-30 | 1995-10-05 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
| DE4429374C1 (de) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente |
-
1997
- 1997-07-23 EP EP97935047A patent/EP0917466B1/en not_active Revoked
- 1997-07-23 AU AU38076/97A patent/AU713016B2/en not_active Ceased
- 1997-07-23 IL IL12792397A patent/IL127923A/en not_active IP Right Cessation
- 1997-07-23 CA CA002261687A patent/CA2261687A1/en not_active Abandoned
- 1997-07-23 WO PCT/US1997/012786 patent/WO1998004268A1/en active IP Right Grant
- 1997-07-23 DE DE69731092T patent/DE69731092T2/de not_active Expired - Fee Related
- 1997-07-23 DK DK97935047T patent/DK0917466T3/da active
- 1997-07-23 CN CN97198093A patent/CN1119999C/zh not_active Expired - Fee Related
- 1997-07-23 SI SI9730679T patent/SI0917466T1/sl unknown
- 1997-07-23 BR BR9710565A patent/BR9710565A/pt not_active Application Discontinuation
- 1997-07-23 JP JP10508919A patent/JP2000515888A/ja not_active Ceased
- 1997-07-23 ES ES97935047T patent/ES2229378T3/es not_active Expired - Lifetime
- 1997-07-23 KR KR10-1999-7000594A patent/KR100501021B1/ko not_active IP Right Cessation
- 1997-07-23 NZ NZ333862A patent/NZ333862A/xx unknown
- 1997-07-23 PT PT97935047T patent/PT917466E/pt unknown
- 1997-07-23 AT AT97935047T patent/ATE278406T1/de not_active IP Right Cessation
- 1997-07-23 HU HU9904345A patent/HUP9904345A3/hu unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL127923A0 (en) | 1999-11-30 |
| HUP9904345A2 (hu) | 2000-06-28 |
| DE69731092D1 (de) | 2004-11-11 |
| IL127923A (en) | 2004-07-25 |
| BR9710565A (pt) | 1999-08-17 |
| DE69731092T2 (de) | 2005-02-10 |
| JP2000515888A (ja) | 2000-11-28 |
| NZ333862A (en) | 2000-08-25 |
| WO1998004268A1 (en) | 1998-02-05 |
| ES2229378T3 (es) | 2005-04-16 |
| AU713016B2 (en) | 1999-11-18 |
| KR20000029537A (ko) | 2000-05-25 |
| KR100501021B1 (ko) | 2005-07-18 |
| CN1119999C (zh) | 2003-09-03 |
| AU3807697A (en) | 1998-02-20 |
| EP0917466A1 (en) | 1999-05-26 |
| PT917466E (pt) | 2004-12-31 |
| CA2261687A1 (en) | 1998-02-05 |
| EP0917466B1 (en) | 2004-10-06 |
| HUP9904345A3 (en) | 2000-11-28 |
| CN1230888A (zh) | 1999-10-06 |
| ATE278406T1 (de) | 2004-10-15 |
| DK0917466T3 (da) | 2004-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69729956D1 (de) | Orale einstufige empfängnisverhütungsmethode und kombinationspräparat das gestagen und estrogen enthält | |
| US5418228A (en) | Contraceptive regimen | |
| CY1105276T1 (el) | Τριφασικο στοματικο αντισυλληπτικο | |
| AU7537987A (en) | Combination dosage form for pre-menopausal women | |
| WO1998004246A3 (en) | Triphasic contraceptive method and kit comprising a combination of a progestin and estrogen | |
| IL127923A0 (en) | Oral contraceptive | |
| AU4043597A (en) | Biphasic contraceptive method and kit comprising a combination of a progestin and estrogen |